Challenges and Future Trends in Atopic Dermatitis.

atopic dermatitis atopic eczema biologic therapy cytokine signaling treatment

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jul 2023
Historique:
received: 19 06 2023
revised: 06 07 2023
accepted: 10 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Atopic dermatitis represents a complex and multidimensional interaction that represents potential fields of preventive and therapeutic management. In addition to the treatment armamentarium available for atopic dermatitis, novel drugs targeting significant molecular pathways in atopic dermatitis biologics and small molecules are also being developed given the condition's complex pathophysiology. While most of the patients are expecting better efficacy and long-term control, the response to these drugs would still depend on numerous factors such as complex genotype, diverse environmental triggers and microbiome-derived signals, and, most importantly, dynamic immune responses. This review article highlights the challenges and the recently developed pharmacological agents in atopic dermatitis based on the molecular pathogenesis of this condition, creating a specific therapeutic approach toward a more personalized medicine.

Identifiants

pubmed: 37511138
pii: ijms241411380
doi: 10.3390/ijms241411380
pmc: PMC10380015
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Immunol. 2019 Sep;20(9):1138-1149
pubmed: 31427775
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):159-66
pubmed: 10887319
JCI Insight. 2016 Jul 7;1(10):
pubmed: 27478874
J Allergy Clin Immunol. 2009 Mar;123(3):619-25
pubmed: 19281909
Pharmaceuticals (Basel). 2018 Oct 06;11(4):
pubmed: 30301231
BioDrugs. 2023 May;37(3):279-293
pubmed: 36867370
J Am Acad Dermatol. 2018 May;78(5):872-881.e6
pubmed: 29353025
Int J Mol Sci. 2019 Mar 13;20(6):
pubmed: 30871134
J Asthma Allergy. 2022 Oct 25;15:1527-1537
pubmed: 36316998
JID Innov. 2021 Sep 23;1(3):100059
pubmed: 34909740
J Immunol. 2013 Dec 1;191(11):5371-82
pubmed: 24140646
J Pharmacol Exp Ther. 2023 Feb;384(2):248-253
pubmed: 36351795
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):365-372
pubmed: 34679239
Pharmaceutics. 2022 Dec 08;14(12):
pubmed: 36559247
Immunohorizons. 2021 Jul 29;5(7):581-589
pubmed: 34326199
JAMA Dermatol. 2015 May;151(5):555-6
pubmed: 25715176
Br J Dermatol. 2002 Feb;146(2):221-7
pubmed: 11903231
J Allergy Clin Immunol. 2017 Jun;139(6):1861-1872.e7
pubmed: 27931974
Pharmacol Ther. 2023 Mar;243:108355
pubmed: 36739914
Allergol Int. 2023 Apr 24;:
pubmed: 37100717
J Dermatol Sci. 2019 Oct;96(1):2-7
pubmed: 31455506
J Dermatol Sci. 2013 Oct;72(1):3-8
pubmed: 23746568
J Ethnopharmacol. 2018 Oct 28;225:342-358
pubmed: 29801717
Exp Dermatol. 2018 Apr;27(4):340-357
pubmed: 29457272
Pharmacol Rev. 2006 Sep;58(3):488-520
pubmed: 16968949
Allergol Int. 2022 Jan;71(1):14-24
pubmed: 34344611
Br J Pharmacol. 1999 Dec;128(7):1393-8
pubmed: 10602317
Biomolecules. 2021 Jul 13;11(7):
pubmed: 34356643
J Allergy Clin Immunol. 2018 Mar;141(3):858-866
pubmed: 29366565
Cell Host Microbe. 2017 Nov 8;22(5):653-666.e5
pubmed: 29120743
J Inflamm (Lond). 2020 May 29;17:20
pubmed: 32514255
J Allergy Clin Immunol. 2019 Mar;143(3):1252-1254.e8
pubmed: 30452925
N Engl J Med. 2023 Mar 23;388(12):1080-1091
pubmed: 36920778
Am J Clin Dermatol. 2022 Jan;23(Suppl 1):51-64
pubmed: 35061230
Allergy. 2021 Oct;76(10):2982-2997
pubmed: 33629401
Front Pharmacol. 2016 Nov 25;7:455
pubmed: 27932984
J Allergy Clin Immunol. 2004 May;113(5):949-57
pubmed: 15131579
Oncotarget. 2017 Jun 27;8(32):53563-53580
pubmed: 28881832
Pain. 2000 Mar;85(1-2):145-51
pubmed: 10692613
J Allergy Clin Immunol. 2016 Dec;138(6):1639-1651
pubmed: 27671162
Immunol Rev. 2018 Jan;281(1):197-232
pubmed: 29248002
Immunol Rev. 2000 Jun;175:120-7
pubmed: 10933597
J Allergy Clin Immunol. 2022 Apr;149(4):1340-1347.e4
pubmed: 34606832
Life (Basel). 2020 Apr 24;10(4):
pubmed: 32344736
Cancer Discov. 2018 Aug;8(8):1026-1043
pubmed: 29907586
Clin Exp Allergy. 2018 Aug;48(8):957-969
pubmed: 29682796
Allergy. 2020 Jan;75(1):54-62
pubmed: 31230370
Pediatr Allergy Immunol. 2010 Mar;21(2 Pt 2):e457-60
pubmed: 20444170
Inflammation. 2020 Feb;43(1):358-369
pubmed: 31720988
J Immunol. 2014 Oct 1;193(7):3717-25
pubmed: 25156365
Int J Mol Sci. 2021 Oct 24;22(21):
pubmed: 34768891
Int J Pharm. 2022 Aug 25;624:122045
pubmed: 35878872
J Invest Dermatol. 2019 May;139(5):1063-1072
pubmed: 30528828
Front Pharmacol. 2020 Dec 14;11:604314
pubmed: 33536914
Am J Clin Dermatol. 2020 Dec;21(6):783-798
pubmed: 32776305
J Invest Dermatol. 2009 Aug;129(8):1892-908
pubmed: 19494826
Dermatol Ther (Heidelb). 2022 Mar;12(3):771-785
pubmed: 35297025
Ann Dermatol. 2022 Dec;34(6):419-430
pubmed: 36478424
Cell Calcium. 2020 May;87:102168
pubmed: 32004816
Br J Dermatol. 2016 Nov;175(5):902-911
pubmed: 27423107
N Engl J Med. 2020 Jul 9;383(2):141-150
pubmed: 32640132
Br J Dermatol. 2022 Jan;186(1):40-49
pubmed: 34289086
Int J Dermatol. 2015 Oct;54(10):e401-8
pubmed: 26095080
Pharmaceutics. 2022 Dec 10;14(12):
pubmed: 36559261
Ann Dermatol. 2016 Feb;28(1):22-9
pubmed: 26848215
Cancer Sci. 2019 Jun;110(6):1931-1946
pubmed: 30974024
J Invest Dermatol. 2020 Aug;140(8):1524-1532
pubmed: 32004565
Curr Opin Mol Ther. 2009 Feb;11(1):81-9
pubmed: 19169963
Br J Dermatol. 2023 May 24;188(6):740-748
pubmed: 36994947
Allergy. 2021 Aug;76(8):2592-2595
pubmed: 33764548
Int J Mol Med. 2017 Jan;39(1):231-237
pubmed: 28004106
EClinicalMedicine. 2023 Feb 03;57:101826
pubmed: 36816342
Sci Rep. 2022 Aug 10;12(1):13626
pubmed: 35948589
Front Immunol. 2022 Dec 08;13:1068260
pubmed: 36569854
J Allergy Clin Immunol. 2019 Jan;143(1):155-172
pubmed: 30194992
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33645549
J Pharmacol Exp Ther. 2014 Jul;350(1):181-7
pubmed: 24817035
Int J Mol Sci. 2023 Mar 29;24(7):
pubmed: 37047385
J Dermatol Sci. 2005 Jun;38(3):177-88
pubmed: 15927811
Int J Mol Sci. 2015 Dec 09;16(12):29357-69
pubmed: 26690141
Br J Dermatol. 2019 Oct;181(4):733-742
pubmed: 30919407
Br J Dermatol. 2011 Jul;165(1):5-17
pubmed: 21219293
Cell Prolif. 2018 Jun;51(3):e12436
pubmed: 29359496
Allergy. 2022 Aug;77(8):2355-2366
pubmed: 35175630
J Exp Med. 2006 Apr 17;203(4):1021-31
pubmed: 16606674
Lancet. 2003 Feb 22;361(9358):690-4
pubmed: 12606187
Am J Clin Dermatol. 2023 Jan;24(1):97-107
pubmed: 36512175
J Neurosci. 2018 Sep 5;38(36):7833-7843
pubmed: 30082422
Biology (Basel). 2019 Jun 27;8(3):
pubmed: 31252572
J Dermatolog Treat. 2020 Dec;31(8):839-845
pubmed: 31599175
Mol Cancer Ther. 2017 Dec;16(12):2803-2816
pubmed: 28878029
Cytokine. 2015 Sep;75(1):38-50
pubmed: 26187331
J Med Chem. 2019 Apr 11;62(7):3228-3250
pubmed: 30893553
Allergy. 2020 Apr;75(4):950-953
pubmed: 31515809
Front Immunol. 2023 Mar 28;14:1056267
pubmed: 37056785
J Invest Dermatol. 2001 Aug;117(2):188-96
pubmed: 11511293
J Invest Dermatol. 2020 Nov;140(11):2199-2209.e6
pubmed: 32247859
J Neurosci. 2003 Jul 16;23(15):6176-80
pubmed: 12867500
Exp Dermatol. 2019 Nov;28(11):1298-1308
pubmed: 31487753
Nat Med. 2003 Aug;9(8):1047-54
pubmed: 12847520
J Invest Dermatol. 2008 Nov;128(11):2625-2630
pubmed: 18432274
J Am Acad Dermatol. 2015 Sep;73(3):395-9
pubmed: 26194706
J Am Acad Dermatol. 2021 Oct;85(4):854-862
pubmed: 34118298
J Immunol. 2002 Jul 1;169(1):434-42
pubmed: 12077274
Br J Dermatol. 2022 Apr;186(4):642-651
pubmed: 34726262
Front Pharmacol. 2018 Oct 17;9:1048
pubmed: 30386231
J Immunol. 2002 Jun 15;168(12):6404-11
pubmed: 12055259
BMC Complement Altern Med. 2016 Aug 20;16(1):299
pubmed: 27544348
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Am J Clin Dermatol. 2021 Nov;22(6):877-889
pubmed: 34374027
Immunity. 2012 Feb 24;36(2):239-50
pubmed: 22342841
Acta Derm Venereol. 2015 May;95(5):542-8
pubmed: 25594427
Clin Pharmacol Ther. 2022 May;111(5):1121-1132
pubmed: 35092305
Nat Rev Drug Discov. 2022 Jan;21(1):21-40
pubmed: 34417579
World Allergy Organ J. 2010 Mar;3(3):44-7
pubmed: 23282416
Br J Dermatol. 2023 Jul 7;189(1):23-32
pubmed: 36999560
Front Immunol. 2020 Aug 12;11:1740
pubmed: 32903402
Clin Exp Dermatol. 2021 Jan;46(1):162-163
pubmed: 32516832
J Exp Med. 2020 Apr 6;217(4):
pubmed: 32031571
J Allergy Clin Immunol. 2022 Dec;150(6):1517-1524
pubmed: 36041655
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1366-1374
pubmed: 36695074
Ann Allergy Asthma Immunol. 2018 Jun;120(6):631-640.e11
pubmed: 29567358
Allergy. 2019 Oct;74(10):1920-1933
pubmed: 30937919
J Allergy Clin Immunol. 2019 May;143(5):1830-1837.e4
pubmed: 30414855
J Am Acad Dermatol. 2018 Mar;78(3 Suppl 1):S63-S66
pubmed: 29248524
Asia Pac Allergy. 2022 Apr 28;12(2):e20
pubmed: 35571547
Protein Sci. 2012 Jun;21(6):850-64
pubmed: 22528658
Evid Based Complement Alternat Med. 2017;2017:8791832
pubmed: 28781601
J Invest Dermatol. 2019 Jul;139(7):1480-1489
pubmed: 30641038
Br J Dermatol. 2022 Dec;187(6):878-887
pubmed: 35986699
Biomol Ther (Seoul). 2020 Nov 1;28(6):537-541
pubmed: 32487782
J Pers Med. 2021 Apr 07;11(4):
pubmed: 33917069
J Allergy Clin Immunol. 2015 Nov;136(5):1254-64
pubmed: 26428954
Sci Rep. 2018 Dec 20;8(1):17999
pubmed: 30573749
Allergy. 2012 Aug;67(8):1014-22
pubmed: 22686688
Clin Transl Sci. 2022 Apr;15(4):1074-1083
pubmed: 35045208
Cell. 2017 Sep 21;171(1):217-228.e13
pubmed: 28890086
Allergy Asthma Immunol Res. 2016 May;8(3):181-90
pubmed: 26922927
Clin Cosmet Investig Dermatol. 2020 Dec 08;13:927-942
pubmed: 33335413
Cell Mol Immunol. 2023 May;20(5):448-474
pubmed: 36928371
Planta Med. 2005 May;71(5):424-8
pubmed: 15931580
J Allergy Clin Immunol. 2019 Oct;144(4):1011-1024
pubmed: 31356921
J Invest Dermatol. 2012 May;132(5):1392-400
pubmed: 22277940
J Allergy Clin Immunol. 2019 Aug;144(2):482-493.e7
pubmed: 30738171
J Invest Dermatol. 2023 Apr;143(4):545-553
pubmed: 36842860
Int J Mol Sci. 2022 Dec 27;24(1):
pubmed: 36613861
Mediators Inflamm. 2023 Apr 15;2023:7697699
pubmed: 37096155
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):e191-e192
pubmed: 27538258
J Am Acad Dermatol. 2014 May;70(5):882-8
pubmed: 24569114
Br J Dermatol. 2022 Sep;187(3):338-352
pubmed: 35484697
J Clin Med. 2022 Aug 24;11(17):
pubmed: 36078904
JAMA Dermatol. 2021 Sep 01;157(9):1047-1055
pubmed: 34347860
Int J Mol Sci. 2022 Aug 22;23(16):
pubmed: 36012744
Front Immunol. 2013 Oct 08;4:289
pubmed: 24115947
Protein Eng. 2003 Feb;16(2):115-24
pubmed: 12676980
J Dermatol Sci. 2020 Feb;97(2):135-142
pubmed: 31982303
J Am Acad Dermatol. 2022 Apr;86(4):854-862
pubmed: 33010325
Br J Dermatol. 2023 Jul 18;:
pubmed: 37463508
J Eur Acad Dermatol Venereol. 2023 Mar;37(3):549-557
pubmed: 36376738
Purinergic Signal. 2023 Mar 22;:
pubmed: 36944825
J Am Acad Dermatol. 2022 Mar;86(3):607-614
pubmed: 34710557
Clin Transl Med. 2022 May;12(5):e790
pubmed: 35522900
Front Pharmacol. 2021 Apr 16;12:657724
pubmed: 33935775
EClinicalMedicine. 2023 May 16;60:102002
pubmed: 37396805
Sci Rep. 2023 Jun 17;13(1):9825
pubmed: 37330528
Br J Dermatol. 2019 May;180(5):1030-1038
pubmed: 30623408
J Eur Acad Dermatol Venereol. 2021 May;35(5):e338-e340
pubmed: 33330999
Front Immunol. 2021 Jun 21;12:670637
pubmed: 34234777
Cell. 2008 Jan 25;132(2):259-72
pubmed: 18243101
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645451
Pharmaceutics. 2023 Feb 08;15(2):
pubmed: 36839890
J Drugs Dermatol. 2023 Feb 1;22(2):139-147
pubmed: 36745371
Eur J Immunol. 2016 Apr;46(4):981-92
pubmed: 26694221
Exp Dermatol. 2014 Jun;23(6):401-6
pubmed: 24750433
J Dermatol Sci. 2021 Mar;101(3):164-173
pubmed: 33358580
Cells. 2021 Dec 30;11(1):
pubmed: 35011670
iScience. 2023 Mar 17;26(4):106442
pubmed: 37020964
Int J Med Sci. 2017 Aug 18;14(10):1002-1007
pubmed: 28924372
Sci Adv. 2023 Jan 6;9(1):eade8898
pubmed: 36608129
J Allergy Clin Immunol. 2003 Apr;111(4):677-90; quiz 691
pubmed: 12704343
Nat Med. 2021 Apr;27(4):700-709
pubmed: 33619370
PLoS One. 2016 Aug 24;11(8):e0161877
pubmed: 27556734

Auteurs

Julius Garcia Gatmaitan (JG)

Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Gatmaitan Medical and Skin Center, Baliuag 3006, Bulacan, Philippines.
Skines Aesthetic and Laser Center, Quezon City 1104, Metro Manila, Philippines.

Ji Hyun Lee (JH)

Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH